MMP9 and ovarian carcinoma: This proteoglycan, in turn, promotes the motility and invasion of ovarian cancer cells by a mechanism involving activation of the NF-κB signaling pathway and overexpression of matrix metalloproteinase-9 (MMP9) and CD44 [52].